skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Transcription factors involved in glucose-stimulated insulin secretion of pancreatic beta cells

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2]; ;  [1]
  1. Division of Endocrinology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan (China)
  2. Division of Orthopedics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan (China)

GSIS, the most important function of pancreatic beta cell, is essential for maintaining the glucose homeostasis. Transcription factors are known to control different biological processes such as differentiation, proliferation and apoptosis. In pancreas, some transcription factors are involved in regulating the function of beta cells. In this review, the role of these transcription factors including Pdx-1, FoxO1, SREBP-1c, and MafA in GSIS is highlighted. The related molecular mechanisms are analyzed as well. Furthermore, the association between the role of transcription factors in GSIS and the development of T2DM is discussed.

OSTI ID:
22199735
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 384, Issue 4; Other Information: Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Nuclear SREBP-1a causes loss of pancreatic {beta}-cells and impaired insulin secretion
Journal Article · Fri Jan 16 00:00:00 EST 2009 · Biochemical and Biophysical Research Communications · OSTI ID:22199735

Heparan sulfate in pancreatic β-cells contributes to normal glucose homeostasis by regulating insulin secretion
Journal Article · Tue May 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:22199735

Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice
Journal Article · Fri Feb 12 00:00:00 EST 2016 · Biochemical and Biophysical Research Communications · OSTI ID:22199735